Shattuck Labs (STTK) Competitors $2.10 +0.29 (+16.02%) Closing price 04:00 PM EasternExtended Trading$2.06 -0.04 (-2.14%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock STTK vs. LBRX, ALT, DMAC, TNYA, ANNX, CADL, EDIT, CTNM, ALTS, and CGCShould you be buying Shattuck Labs stock or one of its competitors? The main competitors of Shattuck Labs include LB Pharmaceuticals (LBRX), Altimmune (ALT), DiaMedica Therapeutics (DMAC), Tenaya Therapeutics (TNYA), Annexon (ANNX), Candel Therapeutics (CADL), Editas Medicine (EDIT), Contineum Therapeutics (CTNM), ALT5 Sigma (ALTS), and Canopy Growth (CGC). These companies are all part of the "pharmaceutical products" industry. Shattuck Labs vs. Its Competitors LB Pharmaceuticals Altimmune DiaMedica Therapeutics Tenaya Therapeutics Annexon Candel Therapeutics Editas Medicine Contineum Therapeutics ALT5 Sigma Canopy Growth LB Pharmaceuticals (NASDAQ:LBRX) and Shattuck Labs (NASDAQ:STTK) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations. Does the media refer more to LBRX or STTK? In the previous week, LB Pharmaceuticals had 2 more articles in the media than Shattuck Labs. MarketBeat recorded 2 mentions for LB Pharmaceuticals and 0 mentions for Shattuck Labs. LB Pharmaceuticals' average media sentiment score of 0.74 beat Shattuck Labs' score of 0.00 indicating that LB Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment LB Pharmaceuticals Positive Shattuck Labs Neutral Which has preferable valuation and earnings, LBRX or STTK? LB Pharmaceuticals has higher earnings, but lower revenue than Shattuck Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLB PharmaceuticalsN/AN/AN/AN/AN/AShattuck Labs$5.72M17.59-$75.41M-$1.21-1.74 Do analysts prefer LBRX or STTK? LB Pharmaceuticals presently has a consensus price target of $30.50, suggesting a potential upside of 90.63%. Shattuck Labs has a consensus price target of $3.00, suggesting a potential upside of 42.86%. Given LB Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe LB Pharmaceuticals is more favorable than Shattuck Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LB Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Shattuck Labs 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50 Is LBRX or STTK more profitable? LB Pharmaceuticals' return on equity of 0.00% beat Shattuck Labs' return on equity.Company Net Margins Return on Equity Return on Assets LB PharmaceuticalsN/A N/A N/A Shattuck Labs N/A -81.80%-71.46% Do insiders & institutionals hold more shares of LBRX or STTK? 58.7% of Shattuck Labs shares are owned by institutional investors. 12.0% of Shattuck Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryLB Pharmaceuticals beats Shattuck Labs on 7 of the 10 factors compared between the two stocks. Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STTK vs. The Competition Export to ExcelMetricShattuck LabsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.71M$3.46B$6.15B$10.56BDividend YieldN/A2.27%5.72%4.84%P/E Ratio-1.748.1920.7122.83Price / Sales17.59482.12586.87132.58Price / CashN/A45.2825.8230.35Price / Book1.2610.6112.526.69Net Income-$75.41M-$52.56M$3.32B$276.46M7 Day Performance14.13%4.94%2.43%0.97%1 Month Performance-7.89%16.10%8.78%3.95%1 Year Performance55.56%14.51%62.11%36.40% Shattuck Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STTKShattuck Labs2.9298 of 5 stars$2.10+16.0%$3.00+42.9%+34.1%$86.71M$5.72M-1.74100LBRXLB PharmaceuticalsN/A$16.07+4.1%$30.50+89.8%N/A$346.52MN/A0.0016Positive NewsQuiet Period ExpirationALTAltimmune2.3697 of 5 stars$4.00+2.0%$17.40+335.0%-44.3%$345.97M$20K-3.3950Analyst ForecastDMACDiaMedica Therapeutics1.0507 of 5 stars$7.06+6.3%$12.33+74.7%+51.6%$343.21MN/A-10.2320TNYATenaya Therapeutics3.4273 of 5 stars$1.98-5.7%$6.25+215.7%-11.3%$342.25MN/A-2.06110Positive NewsGap UpHigh Trading VolumeANNXAnnexon1.5126 of 5 stars$3.01-2.9%$12.50+315.3%-57.9%$340.65MN/A-2.3360CADLCandel Therapeutics2.6495 of 5 stars$6.47+4.5%$20.00+209.1%-12.0%$339.80M$120K-9.3860EDITEditas Medicine4.0963 of 5 stars$3.56-4.3%$5.10+43.3%+12.2%$334.50M$32.31M-1.25230CTNMContineum Therapeutics1.9257 of 5 stars$11.93+0.4%$22.20+86.1%-28.6%$333.14M$50M-5.4231ALTSALT5 Sigma0.6545 of 5 stars$2.43-7.6%N/A-22.0%$329.23M$12.53M0.00170Positive NewsGap DownCGCCanopy Growth0.8988 of 5 stars$1.37flatN/A-70.5%$328.59M$225.65M-0.453,150 Related Companies and Tools Related Companies LB Pharmaceuticals Competitors Altimmune Competitors DiaMedica Therapeutics Competitors Tenaya Therapeutics Competitors Annexon Competitors Candel Therapeutics Competitors Editas Medicine Competitors Contineum Therapeutics Competitors ALT5 Sigma Competitors Canopy Growth Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STTK) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersTesla to LEAVE the car market?Elon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
